CTOs on the Move

Zymeworks

www.zymeworks.com

 
Zymeworks (NASDAQ:ZYME) is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics. Zymeworks` suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of highly differentiated product candidates. Zymeworks` lead clinical candidate, zanidatamab, is a novel Azymetric™ HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. Zymeworks` second product candidate, Zanidatamab Zovodotin (ZW49), is a bispecific antibody-drug conjugate currently in Phase 1 clinical development and combines the unique design and antibody framework ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.zymeworks.com
  • 114 East 4th Avenue Suite 800
    Vancouver, BC CAN V6H 3V9
  • Phone: 604.678.1388

Executives

Name Title Contact Details
John Fann
Senior Vice President of Process Sciences Profile

Similar Companies

BioLuminate

BioLuminate is a Dublin, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Athens Research and Technology

Athens Research and Technology is a Athens, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BioTechniques

BioTechniques is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Allied Biotech

Allied Biotech is a Ijamsville, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.